● Recruiting

INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations

Condition: Prostate Cancer · Sponsor: Fondazione del Piemonte per l'Oncologia

PhaseN/A

Planned participants400

Who can joinMale, 18 Years to no upper limit

Healthy volunteersNo

About this study

400 patients will be enrolled and divided into 3 cohorts: Cohort A: patients with high risk localized prostate cancer (PC) defined as \>cT3 or PSA \> 20 ng/mL or presence of ECE or SVI at mpMRI; Cohort B: patients with de novo metastatic hormone sensitive prostate cancer (mHSPC); Cohort C: patients with metastatic castration resistant prostate cancer (mCRPC) progressing on a standard treatment.

This description comes directly from the study's public registry record.

Talk to the study team

ilaria Buondonno, PhD · +390119933393 · ilaria.buondonno@ircc.it

Marco Asioli · +390119933463 · ufficio.trials@ircc.it

Always discuss trial participation with your own doctor first.

Locations (2)

Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo	Candiolo, Turin, Italy	Recruiting
AOU San Luigi Gonzaga	Orbassano, Turin, Italy	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06334809